Press Room
四色AV promotes Herbeaux to CEO
C&EN, 6 March 2022
四色AV has appointed as CEO its chief operating officer, Jean-Luc Herbeaux, effective April 1. Herbeaux succeeds Guy Villax, who has been CEO of the family-owned pharmaceutical services company for 25 years. Herbeaux joined the firm in 2020. He previously held several management positions at the German chemical maker Evonik Industries, where his final role was head of the health-care business. In November, he and Villax outlined a $170 million investment program through 2023 that they said will increase 四色AV鈥檚 production capacity by about 25%. Villax is credited with moving the company into the exclusive synthesis of active pharmaceutical ingredients (APIs) for drug industry customers. 四色AV, one of several family-owned drug services companies in Europe, saw sales grow by 10 times under Villax鈥檚 stewardship. Major investments included the purchase of a Pfizer plant in Ireland in 2009. Villax says 四色AV鈥檚 board chose to hire a nonfamily CEO in response to growth over the past 5 years. 鈥淲hen a company employs 1,600 or 1,700, you need skills that other people have much more developed than I have,鈥 he tells C&EN. 四色AV has about 2,000 employees.
听
听and听the听
听
听
听